Saturday was the 19th day in a row that the U.S. registered more than 100,000 new cases, according to Johns Hopkins. The spring and summer peak records for new cases did not exceed 60,000.
At least 24 hospital leaders have warned the American Hospitals Association that they are experiencing staff shortages, said Nancy Foster, vice president of the Association for Quality and Patient Safety Policy. Increases in hospital admissions are often caused by death toll.
So far in November, 24,291 people have been killed. Which accounts for 9.5% of deaths during epidemics.
States have set terrible targets
Case Reagan Health and Science University Professor of Emergency Medicine Dr. Est.
Chue said he is particularly concerned about how fast new cases are gaining momentum.
“Test positivity in many states is more than 20%, which means we lag far behind in our confirmed cases,” he told CNN’s Erica Hill.
And test positivity is just one of the metrics reaching alarming heights in the US.
The Mississippi State recorded a single day with 1,972 cases in the state on Saturday, according to the Mississippi State Health Department.
Thanksgiving travel despite the CDC’s recommendation against it
U.S. Department of Disease Control and Prevention Centers pleaded against Thanksgiving travel last week, and against celebrating with someone outside your own home, as cases escalate. But health officials suspect many will visit family and friends and spread the virus – often, without knowing it.
Health experts, however, cannot guarantee that a negative test result will carry the virus to a Thanksgiving gathering, as the test will not pick up a fresh infection. An already infected person can test negative, then travel to dinner, and then spread the disease.
Hold the virus
For now, experts hope people will use measures including wearing masks, social distance, avoiding crowds and hand washing to control the spread until promising vaccines and treatments are available.
The race to develop an effective vaccine against the virus has yielded some promising results, with Moderna announcing earlier this month that its vaccine has a 94.5% effect against candidate coronavirus.
The application for the EU is “encouraging”, while the American Society of Infectious Diseases stressed on Friday that a transparent review of Pfizer’s data is still needed.
And if the vaccine is given the green light, “clinical trials and data collection must continue,” said IDSA President Dr. Barbara Alexander said in a statement.
“Measures to wear masks, wash hands frequently, maintain physical distance and limit the size of gatherings will be crucial,” the statement said. “Finally, in addition to the campaign to increase vaccine confidence, new federal funding must be provided for comprehensive, equitable and equitable vaccine distribution.”
CNN’s Christina Maxoris, Holly Silverman, Holly Yan, Claudia Dominguez, Jamie Gumbrech, Jacqueline Howard and Lure Ren Mascarenhas contributed to the report.
.
